Pharma & Biotech

CureVac is preparing to conclude its journey as an independent entity, but not before delivering a significant financial surprise. As...

The independent trading journey of Chinook Therapeutics shares has concluded. In a strategic move finalized in August 2023, the biotechnology...

Investors in French vaccine developer Valneva are facing a period of intense uncertainty. The company's latest financial report presents a...

While market sentiment remains divided, a significant move by a major investment firm suggests growing institutional confidence in gene-editing specialist...

Investors in Bionxt Solutions are grappling with a puzzling market dynamic where positive corporate developments appear disconnected from share price...

A biotechnology firm finds itself caught between groundbreaking scientific progress and significant market headwinds. Capricor Therapeutics is currently experiencing the...

Investor confidence in Danish pharmaceutical giant Novo Nordisk took a substantial hit this week following disappointing clinical trial results and...

Bruker Corporation is capturing investor attention with a powerful combination of strategic acquisition activity and impressive quarterly earnings. Shareholders have...

Pharmaceutical giant Bristol-Myers Squibb finds itself navigating contrasting currents as recent European regulatory approvals clash with a significant clinical trial...

Assembly Biosciences has captured significant market attention following a substantial price advance in recent weeks. The biotech firm's equity is...